AVR 2.02% $17.00 anteris technologies ltd

Ann: Montefiore enrolls Patients in US Early Feasibility Study, page-24

  1. 13,921 Posts.
    lightbulb Created with Sketch. 125
    What a piss weak response in share price. I guess the market is focussing on the cap raise. It's time for a partnership Wayne, a nice upfront and 50% royalties. No more dilution Wayne.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.